Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital
Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital
Tonix Pharmicals 已在馬薩諸塞州綜合醫院招收了第一位參與者 TNX-1900(鼻內增強催產素)治療兒科肥胖症的 “POWER” 第二階段 “POWER” 研究
Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital
Tonix Pharmicals 已在馬薩諸塞州綜合醫院招收了第一位參與者 TNX-1900(鼻內增強催產素)治療兒科肥胖症的 “POWER” 第二階段 “POWER” 研究